A multifaceted analysis of immune-endocrine-metabolic alterations in patients with pulmonary tuberculosis

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Santucci, Natalia ^a   D'Attilio, Luciano ^a   Kovalevski, Leandro ^b   Bozza, Verónica ^a   Besedovsky, Hugo ^c   del Rey, Adriana ^c   Bay, María Luisa ^a   Bottasso, Oscar ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CONCANAVALIN A; GAMMA INTERFERON; GHRELIN; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; PRASTERONE; CYTOKINE; HORMONE;

ADULT; AGED; ARTICLE; BODY MASS; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; INTERFERON INDUCTION; LUNG TUBERCULOSIS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; METABOLISM; NEUROENDOCRINE SYSTEM; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION; ADOLESCENT; BLOOD; CASE CONTROL STUDY; DISCRIMINANT ANALYSIS; ENDOCRINE SYSTEM; FAMILY SIZE; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; CYTOKINES; DISCRIMINANT ANALYSIS; ENDOCRINE SYSTEM; FAMILY CHARACTERISTICS; FEMALE; HORMONES; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 80054084045     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026363     Document Type: Article

References (52)

1. World Health Organization (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Available: http://www.who.int/tb/publications/2010/978924599191/en/index.html.
2. Dannenberg AM Jr, Rook GA, (1994) Pathogenesis of pulmonary tuberculosis: an interplay between tissue-damaging and macrophage-activating immune responses: dual mechanisms that control bacillary multiplication. In: Bloom BR, editors. Tuberculosis: pathogenesis, protection, and control, ASM Press, Washington, DC, pp. 459-484.
3. Flynn JL, (2004) Immunology of tuberculosis and implications in vaccine development. Tuberculosis 84: 93-101.
4. Grange JM, Brunet LR, Rieder HL, (2011) Immune protection against tuberculosis-when is immunotherapy preferable to vaccination? Tuberculosis 91: 179-185.
5. Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F, (2009) Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol 10: 943-948.
6. Farebee SH, (1970) Controlled chemoprophylaxis trials in tuberculosis. A review. Advanc Tuberc Res 7: 29-106.
7. Cardona PJ, (2011) A Spotlight on liquefaction: Evidence from clinical settings and experimental models in tuberculosis. Clin Dev Immunol 868246 Epub 2011 Mar 13.
8. Bottasso O, Bay ML, Besedovsky H, del Rey A, (2010) The immune-endocrine-metabolic unit during human tuberculosis. Current Immunol Rev 6: 314-322.
9. Hotamisligil G, Erbay E, (2008) Nutrient sensing and inflammation in metabolic diseases. Nature Rev Immunol 8: 923-934.
10. Straub RH, (2011) Concepts of evolutionary medicine and energy regulation contribute to the etiology of systemic chronic inflammatory diseases. Brain Behav Immun 25: 1-5.
11. del Rey A, Mahuad C, Bozza V, Bogué C, Farroni M, et al. (2007) Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain Behav Immun 21: 171-179.
12. Mahuad C, Bozza V, Pezzotto SM, Bay ML, Besedovsky H, et al. (2007) Impaired Immune Responses in tuberculosis patients are related to weight loss that coexists with an immunoendocrine imbalance. Neuroimmunomodulation 14: 193-199.
13. Langhans W, (2000) Anorexia of Infection: Current Prospects Nutrition 16: 996-1005.
14. Anderson TW, Hoboken NJ, (2003) An Introduction to Multivariate Statistical Analysis, 3rd ed. London John Wiley & Sons.
15. Fix E, Hodges Jr JL, (1989) Discriminatory Analysis. Nonparametric Discrimination: Consistency Properties. Int Statistical Rev 57: 238-247.
16. Bozza V, D'Attilio L, Didoli G, Santucci N, Nannini L, et al. (2009) The adrenal steroid response during tuberculosis and its effects on the mycobacterial-driven IFN-γ production of patients and their household contacts. Ann NY Acad Sci 1153: 247-255.
17. Martin SS, Qasim A, Reilly MP, (2008) Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 52: 1201-1210.
18. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS, (2010) Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications. Ann Intern Med 152: 93-100.
19. Yuksel I, Sencan M, Dokmetas HS, Dokmetas I, Ataseven H, et al. (2003) The relation between serum leptin levels and body fat mass in patients with active lung tuberculosis. Endocr Res 29: 257-264.
20. Kim JH, Lee CT, Yoon HI, Song J, Shin WG, Lee JH, (2010) Relation of ghrelin, leptin and inflammatory markers to nutritional status in active pulmonary tuberculosis. Clinical Nutrition 29: 512-518.
21. van Crevel R, Karyadi E, Netea MG, Verhoef H, Nelwan RH, et al. (2002) Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation. J Clin Endocrinol Metab 87: 758-763.
22. Schwenk A, Hodgson L, Rayner CFJ, Griffin GE, Macallan DC, (2003) Leptin and energy metabolism in pulmonary tuberculosis. Am J Clin Nutr 77: 392-398.
23. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 1155-1161.
24. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295.
25. Santucci N, D'Attilio L, Besedovsky H, del Rey A, Bay ML, et al. (2010) A clinical correlate of the dysregulated immuno-endocrine response in human tuberculosis. Neuroimmunomodulation 17: 184-187.
26. La Cava A, Matarese G, (2004) The weight of leptin in immunity. Nat Rev Immunol 4: 371-379.
27. Matarese G, Moschos S, Mantzoros CS, (2005) Leptin in immunology. J Immunol 174: 3137-3142.
28. Lara-Castro C, Luo NL, Wallace P, Klein RL, Garvey WT, (2006) Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55: 249-259.
29. Taub D, (2008) Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam Horm 77: 325-346.
30. Lorenzi T, Meli R, Marzioni D, Morroni M, Baragli A, et al. (2009) Ghrelin: a metaboilic signal affecting the reproductive system. Cytokine Growth Factor Rev 20: 137-152.
31. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, et al. (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8: 75-79.
32. Stenlof K, Wernstedt I, Fjallman T, Wallenius V, Wallenius K, et al. (2003) Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. J Clin Endocrinol Metab 88: 4379-4383.
33. Ota K, Wildmann J, Ota T, Besedovsky H, del Rey A, (2009) IL-1β and insulin elicit different neuro-endocrine responses to hypoglycemia. Ann NY Acad Sci 1153: 82-88.
34. Luheshi GN, Gardner JD, Rushforth DA, Loudon AS, Rothwell NJ, (1999) Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci USA 96: 7047-7052.
35. Dallman M, Strack A, Akana S, Bradbury MJ, Hanson ES, et al. (1993) Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 14: 303-347.
36. Kellendonk C, Eiden S, Kretz O, Schütz G, Schmidt I, et al. (2002) Inactivation of the GR in the nervous system affects energy accumulation. Endocrinology 143: 2333-2340.
37. Schleicher GK, Herbert V, Brink A, Martin S, Maraj R, et al. (2005) Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur Respir J 25: 688-692.
38. Choi CM, Kang CI, Jeung WK Kim DH, Lee CH, et al. (2007) Role of the C-reactive protein for the diagnosis of TB among military personnel in South Korea. Int J Tuberc Lung Dis 11: 233-236.
39. Breen RAM, Leonard O, Perrin FMR, Smith CJ, Bhagani, et al. (2008) How good are systemic symptoms and blood inflammatory markers at detecting individuals with tuberculosis? Int J Tuberc Lung Dis 12: 44-49.
40. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, et al. (2010) Biomarkers and diagnostics for tuberculosis: progress, needs and translation into practice. Lancet 375: 1920-1937.
41. Raso GM, Pacilio M, Esposito E, Coppola A, Di Carlo R, et al. (2002) Leptin potentiates IFN-gamma-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A. 1. Br J Pharmacol 137: 799-804.
42. Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, et al. (2007) The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest 30: 210-214.
43. Bozza V, D'Attilio L, Mahuad C, Giri A, del Rey A, et al. (2007) Altered Cortisol/DHEA ratio in tuberculosis patients and its relationship with abnormalities in the mycobacterial-driven cytokine production by peripheral blood mononuclear cells. Scand J Immunol 66: 97-103.
44. Bottasso O, Bay ML, Besedovsky H, del Rey A, (200) Immuno-endocrine alterations during human tuberculosis as an integrated view of disease pathology. Neuroimmunomodulation 16: 68-77.
45. Dillon J, (2005) Dehydroepiandrosterone, Dehydroepiandrosterone Sulfate and Related Steroids: Their Role in Inflammatory, Allergic and Immunological Disorders. Current Drug Targets- Inflammation Allergy 4: 377-385.
46. Straub RH, Besedovsky HO, (2003) Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J 17: 2176-2183.
47. Baccan GC, Oliveira F, Sousa AD, Cerqueira NA, Costa JM, et al. (2011) Hormone levels are associated with clinical markers and cytokine levels in human localized cutaneous leishmaniasis. Brain Behav Immun 25: 548-554.
48. Pérez AR, Silva-Barbosa SD, Berbert LR, Revelli S, Beloscar J, et al. (2011) Immuno-endocrine alterations in patients with progressive forms of chronic Chagas disease. J Neuroimmunol 235: 84-90.
49. Hernández-Pando R, Aguilar-Leon D, Orozco H, Serrano A, Ahlem C, et al. (2005) 16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. J Infect Dis 191: 299-306.
50. Ribeiro F, Lopes RP, Nunes CP, Maito F, Bonorino C, et al. (2007) Dehydroepiandrosterone sulphate enhances IgG and interferon-gamma production during immunization to tuberculosis in young but not aged mice. Biogerontology 2007 8: 209-220.
51. Morrison J, Pai M, Hopewell PC, (2008) Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infec Dis 8: 359-368.
52. Besedovsky H, del Rey A, (1996) Immune-neuro-endocrine interactions: Facts and Hypothesis. Endocr Rev 17: 64-95.